Amgen (Nasdaq: AMGN) and Abgenix (Nasdaq: ABGX) announced that Amgen has completed the Biologic License Application (BLA) submission with the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE